Assesses performance of merged ocean-colour chlorophyll-a products in the global ocean, indicating user selection guidance.
Chlorophyll a (Chl a), a proxy for phytoplankton biomass, is an important variable used to assess the health and state of the oceans, which are under increasing anthropogenic pressure.With the availability of global ocean-colour Chl a that now spans 25 years, there has been a concerted effort to produce merged data products to assess changes in Chl a over the global ocean as a result of both natural cycles and anthropogenic effects. To date, there has been no independent and rigorous assessment of the performance of these Chl a products to allow users to select the most suitable product, which is the objective of this paper. For this, we assembled a large global in situ dataset resulting in > 13000 in situ Chl a-satellite matchup data points. A comprehensive suite of merged ocean-colour products were assessed, which include two OC-CCI data streams (OC-CCI v5 and OC-CCI v6), two GlobColour data streams (using weighted averaging [AVW] and the GSM model) and the Copernicus Marine Environment Monitoring Service (CMEMS) GlobColour L3 and L4 and CMEMS-CCI products. The validation analysis showed that all these ocean-colour merged data products exhibited consistent results with the in situ Chl a data with an RPD of 15% (after removal of one dataset that was consistently overestimated by all products).
No takes yet. Share an insight, caveat, or question.
Pardo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: